Clorox Reports Q1 Fiscal Year 2026 Results, Updates Outlook

Reports sales and earnings decline primarily due to expected impact of ERP transition

OAKLAND, Calif., Nov. 3, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2026, which ended September 30, 2025.

First-Quarter Fiscal Year 2026 Summary

Following is a summary of key results for the first quarter, which reflects the impact from incremental shipments associated with the enterprise resource planning transition in the U.S. (incremental ERP shipments) in the prior fiscal year and the prior divestiture of the Better Health Vitamins, Minerals and Supplements (VMS) business. All comparisons are with the first quarter of fiscal year 2025 unless otherwise stated.

At the end of the fourth quarter of fiscal year 2025, the company shipped about two weeks of inventory ahead of consumption as retailers built up stock in anticipation of its ERP transition. As retailers drew down on these inventories this quarter, it resulted in year-over-year shipment decline.

"This quarter's ERP launch marks a significant milestone in our transformation journey, empowering faster execution, greater productivity, and deeper insights — all aimed at delivering superior value to our consumers," said Chair and CEO Linda Rendle "As with any rollout of this scale, we experienced some temporary disruptions that affected our market share. With the majority of the rollout now behind us, our focus is now squarely on accelerating profitable growth through innovation and strong demand-creation initiatives in the second half of this fiscal year. Leveraging our rich consumer insights and new advanced digital tools, we're well positioned to drive growth and continue delivering superior value even as consumers navigate ongoing uncertainty and volatility."

This press release includes certain non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more details.

1Organic sales growth / (decrease) and adjusted EPS are non-GAAP measures. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

Strategic and Operational Highlights

The following are recent strategic and operational highlights:

Key Segment Results

The following is a summary of key first-quarter results by reportable segment. All comparisons are with the first quarter of fiscal year 2025 unless otherwise stated.

Net sales decreased 19%, driven by 18 points of lower volume and about 1 point of unfavorable price mix. Lower volume was mainly driven by shipment decline as retailers drew down on the incremental inventory they built in advance of its ERP transition in the fourth quarter of last fiscal year.

Health and Wellness (Cleaning; Professional Products)

Household (Bags and Wraps; Cat Litter; Grilling)

Lifestyle (Food; Water Filtration; Natural Personal Care)

International (Sales Outside the U.S.)

2 Adjusted EBIT is a non-GAAP measure. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

ERP Transition Impact

During the fourth quarter of fiscal year 2025, retailers placed orders in advance of the company's ERP system transition in the U.S. to minimize any potential inventory impacts during the implementation phase. During the first quarter of fiscal year 2026, retailers depleted this inventory, resulting in lower shipments. From a year-over-year sales growth perspective, the reduction in sales from this inventory draw down translates to about 7.5 points of decline in fiscal year 2026 as compared to the higher base in fiscal year 2025. Inventory draw down is expected to reduce fiscal year 2026 earnings per share by about 90 cents. In comparison to the higher base in fiscal year 2025, this results in a year-over-year reduction of about 30% to fiscal year 2026 diluted earnings per share and about 23% to fiscal year 2026 adjusted earnings per share.

Fiscal Year 2026

Net sales (percentage change versus the year ago period)

Three months ended

9/30/2025

Net sales growth / (decrease) (GAAP)

(19) %

Add: Foreign Exchange

—

Add/(Subtract): Divestitures/acquisitions

Organic sales growth / (decrease) (non-GAAP)

(17) %

Note: Approximate impact from incremental shipments related to ERP transition

(14) %

Diluted earnings per share

Three months ended

9/30/2025

As reported (GAAP)

$ 0.65

Digital capabilities and productivity enhancements investment

0.20

As adjusted (non-GAAP)

$ 0.85

Note: Approximate impact from incremental shipments related to ERP transition

$ (0.90)

Fiscal Year 2026 Outlook

The company is maintaining its full year outlook for net sales, gross margin and adjusted EPS. The impact of the order fulfillment challenges experienced earlier in the year, which led to consumption and market share losses, keeps the company's current expectations towards the lower end of the range. This guidance also reflects slightly lower input costs and a strengthened demand creation plan to support share and sales growth in the second half of the fiscal year.

The company is confirming the following elements of its fiscal year 2026 outlook:

Net sales (percentage change versus the year ago period)

Fiscal year 2025

full year

Fiscal year 2026 full year outlook

Impact

Low

High

Net sales growth / (decrease) (GAAP)

0 %

(10) %

(6) %

Add: Foreign Exchange

—

Add/(Subtract): Divestitures/acquisitions

Organic sales growth / (decrease) (non-GAAP)

5 %

(9) %

(5) %

Note: Approximate impact from incremental shipments related to

ERP transition

3.5 %

(7.5) %

Diluted earnings per share

Fiscal year 2025

full year

Fiscal year 2026 full year outlook

Impact

Low

High

As estimated (GAAP)

$ 6.52

$ 5.60

$ 5.95

Loss on divestiture

0.94

—

Cyberattack costs, net of insurance recoveries

(0.42)

—

Digital capabilities and productivity enhancements investment

0.68

0.35

As adjusted (non-GAAP)

$ 7.72

$ 5.95

$ 6.30

Note: Approximate impact from incremental shipments related to

ERP transition

$ 0.90

$ (0.90)

Clorox Earnings Conference Call Schedule

At approximately 4:15 p.m. ET today, Clorox will post prepared management remarks regarding its first quarter fiscal year 2026 results.

At 5 p.m. ET today, the company will host a live Q&A audio webcast with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet to discuss the results.

Links to the live (and archived) webcast, press release and prepared remarks can be found at Clorox Quarterly Results.

For More Detailed Financial Information

Visit the company's Quarterly Results for the following:

Note: Percentage and basis-point, or point, changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate.

About The Clorox Company

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Chux®, Clorinda® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first U.S. companies to integrate sustainability into its business reporting. In 2025 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit thecloroxcompany.com to learn more.

CLX-F

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: unfavorable general economic and geopolitical conditions beyond our control, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, terrorism, and unstable geopolitical conditions, including ongoing conflicts and rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including actual and potential shifts in U.S. and foreign trade policies, including as a result of escalating trade tensions between the U.S. and its trading partners, especially China, particularly as a result of the imposition of U.S. and retaliatory tariffs; the impact of market and category declines, and the company's product and geographic mix on its ability to meet sales growth targets; the company's ability to successfully execute or realize the anticipated benefits of its strategic or transformational initiatives, including the ERP transition and the related timing and volume of shipment movement related to the ERP transition; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; intense competition in the company's markets; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including due to regulatory uncertainty and lack of regulatory convergence among different jurisdictions; lower revenue, increased costs, other financial statement impacts or reputational harm resulting from government actions, compliance with regulations, or any material costs imposed by changes in regulation; the company's ability to maintain its business reputation and the reputation of its brands and products; dependence on key customers and risks related to customer consolidation and ordering patterns; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages; changes to our processes and procedures as a result of our digital capabilities and productivity enhancements that may result in changes to the company's internal controls over financial reporting; risks related to the acquisition of The Procter & Gamble Company's interest in the Glad business; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade policy and tariffs, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; potential operational or supply chain disruptions from wars and military conflicts, including ongoing conflicts and rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies; and the possibility of nationalization, expropriation of assets or other government action or inaction, including the impacts of a prolonged U.S. government shutdown; the impact of climate change and other sustainability issues on sales, operating costs, reputation or stakeholder relationships; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to our reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company; the company's ability to pay and declare dividends or repurchase its stock in the future; and the impacts of potential stockholder activism.

The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Non-GAAP Financial Information

Digital Capabilities and Productivity Enhancements Investment

As announced in August 2021, the company plans to invest in transformative technologies and processes over a five-year period. This investment began in fiscal year 2022, and includes replacement of the company's ERP system and transitioning to a cloud-based platform as well as the implementation of a suite of other digital technologies. The total incremental transformational investment is expected to be approximately $580 million. It is expected that these implementations will generate efficiencies and transform the company's operations in the areas of supply chain, digital commerce, innovation, brand building and more over the long term.

Of the total investment, approximately 75% is expected to represent incremental operating costs primarily recorded within selling and administrative expenses to be adjusted from reported EPS for purposes of disclosing adjusted EPS through fiscal year 2026. About 70% of these operating costs are expected to be related to the implementation of the ERP, with the remaining costs primarily related to the implementation of complementary technologies.

Due to the nature, scope and magnitude of this investment, these costs are considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, will cease at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

The following table provides reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease), the most comparable GAAP measure:

Three months ended September 30, 2025

Percentage change versus the year-ago period

Health and

Wellness

Household

Lifestyle

International

Total

Company (1)

Net sales growth / (decrease) (GAAP)

(19) %

(23) %

(2) %

(19) %

Add: Foreign exchange

—

Add/(Subtract): Divestitures/acquisitions (2)

—

Organic sales growth / (decrease) (non-GAAP)

(19) %

(23) %

(2) %

(17) %

(1)

Total Company includes Corporate and Other. Corporate and Other includes the results of the Better Health VMS business through the date of divestiture.

(2)

The divestiture impact is calculated as net sales from the Better Health VMS business after the sale date in the three month year-ago period.

The following tables provide reconciliations of adjusted diluted earnings per share (non-GAAP) to diluted earnings per share, the most comparable GAAP measure:

Adjusted Diluted Earnings Per Share (EPS)

(Dollars in millions except per share data)

Diluted earnings per share

Three months ended

9/30/2025

9/30/2024

% Change

As reported (GAAP)

$ 0.65

$ 0.80

(19) %

Loss on divestiture (1)

—

0.94

Cyberattack costs, net of insurance recoveries (2)

—

(0.06)

Digital capabilities and productivity enhancements investment (3)

0.20

0.18

As adjusted (non-GAAP)

$ 0.85

$ 1.86

(54) %

(1)

During the three months ended September 30, 2024, the company incurred an after tax charge of $118 related to the divestiture of the Better Health VMS business.

(2)

During the three months ended September 30, 2024, the company recognized approximately $10 ($8 after tax) of insurance recoveries related to the cyberattack.

(3)

During the three months ended September 30, 2025, the company incurred approximately $32 ($25 after tax), and during the three months ended September 30, 2024, the company incurred approximately $29 ($22 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following:

Three months ended

9/30/2025

9/30/2024

External consulting fees (a)

$ 25

$ 20

IT project personnel costs (b)

Other (c)

Total

$ 32

$ 29

(a)

Comprised of third-party consulting fees incurred to assist in the project management and end-to-end systems integration of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.

(b)

Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business.

(c)

Comprised of various other expenses associated with the company's new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses.

Full year 2026

outlook (estimated range)

Diluted earnings per share

Low

High

As estimated (GAAP)

$ 5.60

$ 5.95

Digital capabilities and productivity enhancements investment (4)

0.35

As adjusted (non-GAAP)

$ 5.95

$ 6.30

(4)

In fiscal year 2026, the company expects to incur approximately $60 ($46 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment.

The following table provides reconciliation of adjusted EBIT (non-GAAP) to earnings before income taxes, the most comparable GAAP measure:

Reconciliation of earnings

before income taxes

to adjusted EBIT

Three months ended

9/30/2025

9/30/2024

Earnings before income taxes

$ 107

$ 177

Interest income

(2)

(3)

Interest expense

Loss on divestiture

—

118

Cyberattack costs, net of insurance recoveries

—

(10)

Digital capabilities and productivity enhancements investment

Adjusted EBIT

$ 160

$ 332

Condensed Consolidated Statements of Earnings (Unaudited)

Dollars in millions, except per share data

Three months ended

9/30/2025

9/30/2024

Net sales

$ 1,429

$ 1,762

Cost of products sold

833

955

Gross profit

596

807

Selling and administrative expenses

277

281

Advertising costs

166

201

Research and development costs

Loss on divestiture

—

118

Interest expense

Other (income) expense, net

(5)

(22)

Earnings before income taxes

107

177

Income tax expense

Net earnings

103

Less: Net earnings attributable to noncontrolling interests

Net earnings attributable to Clorox

$ 80

$ 99

Net earnings per share attributable to Clorox

Basic net earnings per share

$ 0.65

$ 0.80

Diluted net earnings per share

$ 0.65

$ 0.80

Weighted average shares outstanding (in thousands)

Basic

122,629

123,795

Diluted

123,018

124,677

Reportable Segment Information

(Unaudited)

Dollars in millions

Net sales

Three months ended

9/30/2025

9/30/2024

% Change (1)

Health and Wellness

$ 565

$ 698

(19) %

Household

362

447

(19)

Lifestyle

245

320

(23)

International

253

259

(2)

Reportable segment total

1,425

1,724

Corporate and Other (2)

(89)

Total

$ 1,429

$ 1,762

(19) %

Segment adjusted EBIT

Three months ended

9/30/2025

9/30/2024

% Change (1)

Health and Wellness

$ 124

$ 235

(47) %

Household

(55) %

Lifestyle

(42) %

International

(46) %

Reportable segment total

208

396

Corporate and Other (2)

(48)

(64)

Interest income

Interest expense

(23)

(21)

Loss on divestiture (3)

—

(118)

Cyberattack costs, net of insurance recoveries (4)

—

Digital capabilities and productivity enhancements investment (5)

(32)

(29)

Earnings before income taxes

$ 107

$ 177

(40) %

(1)

Percentages based on rounded numbers.

(2)

Corporate and Other includes the Better Health VMS business.

(3)

Represents the loss on divestiture of the Better Health VMS business of $118 for the three months ended September 30, 2024.

(4)

Represents cyberattack insurance recoveries of $10 ($8 after tax) for the three months ended September 30, 2024.

(5)

Represents expenses related to the company's digital capabilities and productivity enhancements investment of $32 ($25 after tax) and $29 ($22 after tax) for the three months ended September 30, 2025 and 2024, respectively.

Condensed Consolidated Balance Sheets

Dollars in millions

9/30/2025

6/30/2025

9/30/2024

(Unaudited)

ASSETS

Current assets

Cash and cash equivalents

$ 166

$ 167

$ 278

Receivables, net

703

821

595

Inventories, net

577

523

594

Prepaid expenses and other current assets

249

109

Total current assets

1,695

1,608

1,576

Property, plant and equipment, net

1,251

1,267

1,242

Operating lease right-of-use assets

318

333

341

Goodwill

1,227

1,229

1,233

Trademarks, net

502

503

Other intangible assets, net

Other assets

476

558

524

Total assets

$ 5,528

$ 5,561

$ 5,497

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

Notes and loans payable

$ 218

$ 4

Current operating lease liabilities

Accounts payable and accrued liabilities

1,927

1,828

1,472

Income Taxes Payable

—

Total current liabilities

2,234

1,919

1,579

Long-term debt

2,485

2,484

2,482

Long-term operating lease liabilities

286

305

315

Other liabilities

365

351

874

Deferred income taxes

Total liabilities

5,390

5,079

5,273

Commitments and contingencies

Stockholders' equity

Preferred stock

—

Common stock

131

Additional paid-in capital

1,326

1,319

1,297

Retained earnings

200

432

Treasury stock

(1,514)

(1,404)

(1,252)

Accumulated other comprehensive net (loss) income

(165)

(157)

(147)

Total Clorox stockholders' (deficit) equity

(22)

321

Noncontrolling interests

160

161

164

Total stockholders' equity

138

482

224

Total liabilities and stockholders' equity

$ 5,528

$ 5,561

$ 5,497

SOURCE The Clorox Company